Ovulation Induction: Clinical Trials

6 trials for Ovulation Induction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Unknown 1

Follow Ovulation Induction: new trials by email Literature Review of Ovulation Induction trials Research Report on Ovulation Induction

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction
Oxytocin, Human Chorionic Gonadotropin - Ovulation Induction, Polycystic Ovary Syndrome
Phase 3CompletedShakeela Ishrat602023-01-012025-08-29
Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome
Vitamin D with calcium and clomiphene citrate, Placebo Oral Tablet with calcium and clomiphene citrate - Ovulation Induction
Phase 3UnknownAin Shams University1862017-07-012018-01-11
Traditional Clomiphene Citrate Administration vs. Stair-step Approach
clomiphene citrate - Ovulatory Dysfunction, Anovulation
Phase 3CompletedUniversity of Oklahoma1202009-10-012018-01-08
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
Gonalef® (Follitropin alfa), Purified pituitary gonadotropin (Fertinorm-P®) - Infertility, Ovulation Induction
Phase 3CompletedMerck KGaA, Darmstadt, Germany3002007-02-012013-12-27
Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization
GONAL-f® - Infertility, Ovulation Induction
Phase 3CompletedMerck KGaA, Darmstadt, Germany2152004-05-112018-04-06
To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen
Follitropin alfa liquid formulation, Follitropin beta liquid formulation - Infertility, Ovulation Induction
Phase 3CompletedMerck KGaA, Darmstadt, Germany342003-11-012014-07-31

Narrower conditions

Infertility (3)  ·  Polycystic Ovary Syndrome (3)  ·  Anovulation (1)  ·  Helping Behavior (1)

Broader conditions

Genital Diseases (5)  ·  Urogenital Diseases (5)  ·  Adnexal Diseases (4)  ·  Endocrine System Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases, Female (4)  ·  Gonadal Disorders (4)  ·  Ovarian Diseases (4)  ·  Cysts (3)  ·  Neoplasms (3)  ·  Ovarian Cysts (3)  ·  Behavior (1)  ·  Social Behavior (1)

Interventions

follitropin alfa (3)  ·  Clomiphene (2)  ·  Calcium (1)  ·  Chorionic Gonadotropin (1)  ·  Glycoprotein Hormones, alpha Subunit (1)  ·  Oxytocin (1)  ·  Urofollitropin (1)  ·  Vitamin D (1)  ·  follitropin beta (1)

Sponsors

Merck KGaA, Darmstadt, Germany (3)  ·  Ain Shams University (1)  ·  Shakeela Ishrat (1)  ·  University of Oklahoma (1)

Countries

Bangladesh (1)  ·  Egypt (1)  ·  Germany (1)  ·  Japan (1)  ·  United States (1)

Top investigators

Christoph Keck, PD, Dr. med. (1)  ·  Kimitoshi Takemura (1)  ·  LaTasha Craig, MD (1)  ·  Shakeela Ishrat, FCPS,MS (1)

Results publications

PMID 18230195, PMID 29699333, PMID 32363556